DFT investigation of atazanavir as potential inhibitor for 2019-nCoV coronavirus M protease

Atazanavir (ATZ) is an antiviral drug synthesized.ATZ is being investigated for potential application against the Coronavirus 2019-nCoV. To find candidate drugs for 2019-nCoV, we have carried out a computational study to screen for effective available drug ATZ which may work as an inhibitor for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahab, Siyamak, Sheikhi, Masoome, Alnajjar, Radwan, Saud, Sultan Al, Khancheuski, Maksim, Strogova, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568473/
https://www.ncbi.nlm.nih.gov/pubmed/33100379
http://dx.doi.org/10.1016/j.molstruc.2020.129461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568473/
https://www.ncbi.nlm.nih.gov/pubmed/33100379
http://dx.doi.org/10.1016/j.molstruc.2020.129461

Ejemplares similares